EE211 Cost-Effectiveness Analysis of Lebrikizumab vs. Alternative Biologics in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis in the UK
Abstract
Authors
Warda Tahir Vanessa Buchanan Jonathan Silverberg Michael Ardern-Jones Laia Solé-Feu Buelent Akmaz Helena Agell-Gimeno Anthony Bewley